We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sloan Kettering Seeks More Sanctions In Drug IP Case

Law360, New York (February 9, 2017, 3:33 PM EST) -- The Sloan Kettering Institute again asked a New York federal judge to sanction a biopharmaceutical company and its counsel in a now-dismissed lawsuit over gene therapy patent rights, saying Wednesday the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.